(Ir) relevance of metformin treatment in patients with metastatic pancreatic cancer: an open-label, randomized phase II trial M Reni, E Dugnani, S Cereda, C Belli, G Balzano, R Nicoletti, D Liberati, ... Clinical cancer research 22 (5), 1076-1085, 2016 | 171 | 2016 |
Diabetes after pancreatic surgery: novel issues M Scavini, E Dugnani, V Pasquale, D Liberati, F Aleotti, G Di Terlizzi, ... Current diabetes reports 15 (4), 16, 2015 | 41 | 2015 |
Integrating T cell metabolism in cancer immunotherapy E Dugnani, V Pasquale, C Bordignon, A Canu, L Piemonti, P Monti Cancer Letters 411, 12-18, 2017 | 38 | 2017 |
A preoperative score to predict early death after pancreatic cancer resection G Balzano, E Dugnani, S Crippa, M Scavini, V Pasquale, F Aleotti, ... Digestive and Liver Disease 49 (9), 1050-1056, 2017 | 35 | 2017 |
β-Cell Differentiation of Human Pancreatic Duct–Derived Cells After In Vitro Expansion E Corritore, E Dugnani, V Pasquale, R Misawa, P Witkowski, J Lei, ... Cellular Reprogramming (Formerly" Cloning and Stem Cells") 16 (6), 456-466, 2014 | 33 | 2014 |
Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients G Balzano, E Dugnani, V Pasquale, G Capretti, MG Radaelli, T Garito, ... Acta diabetologica 51 (5), 801-811, 2014 | 31 | 2014 |
Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma E Dugnani, G Balzano, V Pasquale, M Scavini, F Aleotti, D Liberati, ... Acta diabetologica 53 (6), 945-956, 2016 | 28 | 2016 |
Effect of diabetes on survival after resection of pancreatic adenocarcinoma. A prospective, observational study G Balzano, E Dugnani, A Gandolfi, M Scavini, V Pasquale, F Aleotti, ... PloS one 11 (11), e0166008, 2016 | 26 | 2016 |
Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients E Dugnani, A Gandolfi, G Balzano, M Scavini, V Pasquale, F Aleotti, ... Pancreatology 16 (5), 844-852, 2016 | 22 | 2016 |
Profiling and Targeting of Energy and Redox Metabolism in Grade 2 Bladder Cancer Cells with Different Invasiveness Properties V Pasquale, G Ducci, G Campioni, A Ventrici, C Assalini, S Busti, ... Cells 9 (12), 2669, 2020 | 19 | 2020 |
Tumor heterogeneity: preclinical models, emerging technologies, and future applications M Proietto, M Crippa, C Damiani, V Pasquale, E Sacco, M Vanoni, ... Frontiers in Oncology 13, 1164535, 2023 | 16 | 2023 |
V‐Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct‐Derived Cells Into Insulin‐Secreting Cells E Corritore, YS Lee, V Pasquale, D Liberati, MJ Hsu, CA Lombard, ... Stem cells translational medicine 5 (11), 1525-1537, 2016 | 16 | 2016 |
An Optimized Workflow for the Analysis of Metabolic Fluxes in Cancer Spheroids Using Seahorse Technology G Campioni, V Pasquale, S Busti, G Ducci, E Sacco, M Vanoni Cells 11 (5), 866, 2022 | 13 | 2022 |
Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer V Pasquale, E Dugnani, D Liberati, P Marra, A Citro, T Canu, M Policardi, ... Acta diabetologica 56 (9), 1013-1022, 2019 | 11 | 2019 |
Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome E Dugnani, V Sordi, S Pellegrini, R Chimienti, I Marzinotto, V Pasquale, ... Pancreatology 18 (8), 945-953, 2018 | 11 | 2018 |
Modeling the iatrogenic pancreatic cancer risk after islet autotransplantation in mouse E Dugnani, V Pasquale, D Liberati, A Citro, E Cantarelli, S Pellegrini, ... American Journal of Transplantation 17 (10), 2720-2727, 2017 | 11 | 2017 |
A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma B Ferrara, E Dugnani, V Sordi, V Pasquale, S Pellegrini, M Reni, ... International Journal of Molecular Sciences 23 (18), 10663, 2022 | 7 | 2022 |
Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound E Dugnani, V Pasquale, P Marra, D Liberati, T Canu, L Perani, ... Carcinogenesis 39 (9), 1197-1206, 2018 | 5 | 2018 |
Early consequences of the phospholamban mutation PLN-R14del+/-in a transgenic mouse model C Maniezzi, M Eskandr, C Florindi, M Ferrandi, P Barassi, E Sacco, ... bioRxiv, 2023.04. 05.535536, 2023 | 4 | 2023 |
No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay D Liberati, I Marzinotto, C Brigatti, E Dugnani, V Pasquale, M Reni, ... Cancer Biomarkers 22 (2), 351-357, 2018 | 2 | 2018 |